Wellington Shields Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.01M | Buy |
16,603
+4,105
| +33% | +$239K | 0.15% | 102 |
|
|
2025
Q4 | $674K | Buy |
12,498
+7,006
| +128% | +$337K | 0.1% | 132 |
|
|
2025
Q3 | $248K | Buy |
5,492
+6
| +0.1% | +$280 | 0.04% | 221 |
|
|
2025
Q2 | $254K | Buy |
5,486
+272
| +5% | +$13.4K | 0.04% | 212 |
|
|
2025
Q1 | $318K | Sell |
5,214
-2,536
| -33% | -$148K | 0.06% | 180 |
|
|
2024
Q4 | $438K | Buy |
7,750
+4
| +0.1% | +$223 | 0.08% | 160 |
|
|
2024
Q3 | $401K | Buy |
7,746
+5
| +0.1% | +$235 | 0.07% | 178 |
|
|
2024
Q2 | $321K | Buy |
7,741
+341
| +5% | +$15.3K | 0.06% | 193 |
|
|
2024
Q1 | $401K | Sell |
7,400
-1,191
| -14% | -$60.7K | 0.08% | 167 |
|
|
2023
Q4 | $441K | Sell |
8,591
-153
| -2% | -$8.03K | 0.06% | 156 |
|
|
2023
Q3 | $507K | Buy |
8,744
+2
| +0% | +$123 | 0.07% | 135 |
|
|
2023
Q2 | $559K | Sell |
8,742
-174
| -2% | -$11.7K | 0.07% | 140 |
|
|
2023
Q1 | $618K | Buy |
8,916
+1
| +0% | +$71 | 0.07% | 131 |
|
|
2022
Q4 | $641K | Buy |
8,915
+1
| +0% | +$75 | 0.08% | 124 |
|
|
2022
Q3 | $634K | Buy |
8,914
+1
| +0% | +$73 | 0.15% | 121 |
|
|
2022
Q2 | $686K | Sell |
8,913
-295
| -3% | -$22.5K | 0.09% | 121 |
|
|
2022
Q1 | $687K | Sell |
9,208
-21,453
| -70% | -$1.44M | 0.08% | 149 |
|
|
2021
Q4 | $1.91M | Buy |
30,661
+15,001
| +96% | +$880K | 0.24% | 89 |
|
|
2021
Q3 | $927K | Sell |
15,660
-19,298
| -55% | -$1.27M | 0.13% | 130 |
|
|
2021
Q2 | $2.34M | Sell |
34,958
-3,843
| -10% | -$251K | 0.28% | 78 |
|
|
2021
Q1 | $2.45M | Sell |
38,801
-829
| -2% | -$51.6K | 0.23% | 89 |
|
|
2020
Q4 | $2.46M | Buy |
39,630
+8,656
| +28% | +$532K | 0.33% | 65 |
|
|
2020
Q3 | $1.87M | Sell |
30,974
-3,016
| -9% | -$182K | 0.3% | 67 |
|
|
2020
Q2 | $2M | Sell |
33,990
-2,838
| -8% | -$170K | 0.32% | 65 |
|
|
2020
Q1 | $2.05M | Buy |
36,828
+1,488
| +4% | +$90.9K | 0.39% | 60 |
|
|
2019
Q4 | $2.27M | Buy |
35,340
+3,500
| +11% | +$200K | 0.35% | 69 |
|
|
2019
Q3 | $1.61M | Buy |
31,840
+400
| +1% | +$18.8K | 0.26% | 82 |
|
|
2019
Q2 | $1.43M | Sell |
31,440
-1,253
| -4% | -$58.4K | 0.24% | 91 |
|
|
2019
Q1 | $1.56M | Sell |
32,693
-150
| -0.5% | -$7.47K | 0.27% | 82 |
|
|
2018
Q4 | $1.71M | Sell |
32,843
-2,347
| -7% | -$126K | 0.32% | 72 |
|
|
2018
Q3 | $2.19M | Sell |
35,190
-300
| -0.8% | -$17.8K | 0.35% | 67 |
|
|
2018
Q2 | $1.96M | Sell |
35,490
-5,540
| -14% | -$299K | 0.32% | 67 |
|
|
2018
Q1 | $2.6M | Buy |
41,030
+1,530
| +4% | +$98.4K | 0.39% | 58 |
|
|
2017
Q4 | $2.42M | Sell |
39,500
-2,100
| -5% | -$131K | 0.38% | 56 |
|
|
2017
Q3 | $2.65M | Sell |
41,600
-138
| -0.3% | -$8.06K | 0.44% | 51 |
|
|
2017
Q2 | $2.33M | Sell |
41,738
-99
| -0.2% | -$5.39K | 0.38% | 59 |
|
|
2017
Q1 | $2.27M | Sell |
41,837
-13,900
| -25% | -$762K | 0.37% | 63 |
|
|
2016
Q4 | $3.26M | Buy |
55,737
+6,902
| +14% | +$377K | 0.54% | 39 |
|
|
2016
Q3 | $2.63M | Sell |
48,835
-13,289
| -21% | -$854K | 0.46% | 51 |
|
|
2016
Q2 | $4.57M | Buy |
62,124
+3,605
| +6% | +$255K | 0.77% | 23 |
|
|
2016
Q1 | $3.74M | Sell |
58,519
-2,663
| -4% | -$168K | 0.65% | 31 |
|
|
2015
Q4 | $4.21M | Sell |
61,182
-897
| -1% | -$59.3K | 0.71% | 25 |
|
|
2015
Q3 | $3.67M | Sell |
62,079
-24,746
| -29% | -$1.57M | 0.63% | 30 |
|
|
2015
Q2 | $5.78M | Buy |
86,825
+204
| +0.2% | +$13.4K | 0.88% | 18 |
|
|
2015
Q1 | $5.59M | Buy |
86,621
+1,153
| +1% | +$72.2K | 0.84% | 19 |
|
|
2014
Q4 | $5.04M | Sell |
85,468
-1,196
| -1% | -$67.4K | 0.8% | 23 |
|
|
2014
Q3 | $4.43M | Sell |
86,664
-1,995
| -2% | -$99.7K | 0.74% | 22 |
|
|
2014
Q2 | $4.3M | Sell |
88,659
-596
| -0.7% | -$29.4K | 0.67% | 24 |
|
|
2014
Q1 | $4.64M | Buy |
89,255
+505
| +0.6% | +$26.9K | 0.79% | 19 |
|
|
2013
Q4 | $4.72M | Buy |
88,750
+4
| +0% | +$204 | 0.85% | 17 |
|
|
2013
Q3 | $4.11M | Buy |
88,746
+155
| +0.2% | +$6.8K | 0.79% | 16 |
|
|
2013
Q2 | $3.96M | Buy |
+88,591
| New | +$3.85M | 0.7% | 19 |
|
Other funds holding BMY
VCM
VPM
Wellington Shields Capital Management's BMY Position: Q1 2026 in Review
Wellington Shields Capital Management increased its Bristol-Myers Squibb (BMY) stake by 33% in Q1 2026, buying an estimated $239K and bringing the position to 16,603 shares worth $1.01M. The position accounts for 0.15% of the portfolio, ranked #102.
Wellington Shields Capital Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.78M in Q2 2015. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Wellington Shields Capital Management held 16,603 shares of Bristol-Myers Squibb worth $1.01M as of Q1 2026.
- Wellington Shields Capital Management bought 4,105 Bristol-Myers Squibb shares in Q1 2026, an estimated $239K.
- Bristol-Myers Squibb made up 0.15% of Wellington Shields Capital Management's portfolio in Q1 2026, its #102 holding.
- Wellington Shields Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Wellington Shields Capital Management's Bristol-Myers Squibb position peaked at $5.78M in Q2 2015.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Wellington Shields Capital Management's 13F filing for Q1 2026, filed 4 May 2026.